No Data
No Data
New Analyst Forecast: $CLDX Given $46.0 Price Target
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Celldex Therapeutics Initiated at Overweight by Morgan Stanley
Morgan Stanley Initiates Celldex Therapeutics(CLDX.US) With Buy Rating, Announces Target Price $46
Celldex Therapeutics Insiders Sold US$2.1m Of Shares Suggesting Hesitancy
Celldex Therapeutics to Present at Upcoming Investor Conferences